» Articles » PMID: 1705243

Antigens of Actinobacillus Actinomycetemcomitans Recognized by Patients with Juvenile Periodontitis and Periodontally Normal Subjects

Overview
Journal Infect Immun
Date 1991 Mar 1
PMID 1705243
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Most juvenile periodontitis patients respond to infection by Actinobacillus actinomycetemcomitans by producing serum antibodies. Specific antigens inducing the humoral immune response have not been identified, nor has the role of the resulting antibodies in disease progression been determined. Adsorbed and unadsorbed sera from juvenile periodontitis patients and normal subjects were analyzed by enzyme-linked immunosorbent assay and Western blots (immunoblots), using digested and undigested bacterial sonicates and French pressure cell fractions to determine the biochemical class, cross-reactivity, and cellular location of the antigens in different A. actinomycetemcomitans serotypes. Antigens detected by using high-titer sera included the following: (i) serotype-specific nonprotein material located on the cell surface, (ii) soluble-fraction proteins showing highly variable antibody binding, (iii) cross-reactive proteins, and (iv) a protein present in soluble and cell wall fractions and immunopositive for all sera tested. In addition, one apparently nonprotein component that was enriched in the cell wall fraction was observed. Sera with high immunoglobulin G titers to one, two, three, or none of the three A. actinomycetemcomitans serotypes were observed. There was a high degree of variation from one patient to another in the humoral immune response to serotype-specific and cross-reactive antigens. As demonstrated by whole-cell adsorption experiments, the serotype-specific surface antigen accounted for approximately 72 to 90% of the total antibody-binding activity for sera with titers greater than 100-fold above background, while cross-reactive antigen accounted for less than 28%. Antibody binding the whole-cell sonicate for high-titer sera was inhibited 90% by lipopolysaccharide from the same serotype, strongly suggesting that lipopolysaccharide is the immunodominant antigen class.

Citing Articles

Extracellular vesicles from Aggregatibacter actinomycetemcomitans exhibit potential antitumorigenic effects in oral cancer: a comparative in vitro study.

Metsaniitty M, Hasnat S, Ohman C, Salo T, Eklund K, Oscarsson J Arch Microbiol. 2024; 206(6):244.

PMID: 38702412 PMC: 11068833. DOI: 10.1007/s00203-024-03976-8.


Outer membrane vesicle-mediated serum protection in .

Lindholm M, Metsaniitty M, Granstrom E, Oscarsson J J Oral Microbiol. 2020; 12(1):1747857.

PMID: 32363008 PMC: 7178816. DOI: 10.1080/20002297.2020.1747857.


Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis.

Xynogala I, Volgina A, DiRienzo J, Korostoff J Oral Microbiol Immunol. 2009; 24(2):116-23.

PMID: 19239638 PMC: 2732719. DOI: 10.1111/j.1399-302X.2008.00483.x.


Actinobacillus actinomycetemcomitans serotype d-specific antigen contains the O antigen of lipopolysaccharide.

Lakio L, Paju S, Alfthan G, Tiirola T, Asikainen S, Pussinen P Infect Immun. 2003; 71(9):5005-11.

PMID: 12933843 PMC: 187330. DOI: 10.1128/IAI.71.9.5005-5011.2003.


Actinobacillus actinomycetemcomitans serotype b lipopolysaccharide mediates coaggregation with Fusobacterium nucleatum.

Rosen G, Nisimov I, Helcer M, Sela M Infect Immun. 2003; 71(6):3652-6.

PMID: 12761156 PMC: 155709. DOI: 10.1128/IAI.71.6.3652-3656.2003.


References
1.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

2.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

3.
Vincent J, Suzuki J, Falkler Jr W, Cornett W . Reaction of human sera from juvenile periodontitis, rapidly progressive periodontitis, and adult periodontitis patients with selected periodontopathogens. J Periodontol. 1985; 56(8):464-9. DOI: 10.1902/jop.1985.56.8.464. View

4.
Smith D, Gadalla L, Ebersole J, Taubman M . Gingival crevicular fluid antibody to oral microorganisms. III. Association of gingival homogenate and gingival crevicular fluid antibody levels. J Periodontal Res. 1985; 20(4):357-67. DOI: 10.1111/j.1600-0765.1985.tb00447.x. View

5.
Ebersole J, Taubman M, Smith D . Gingival crevicular fluid antibody to oral microorganisms. II. Distribution and specificity of local antibody responses. J Periodontal Res. 1985; 20(4):349-56. DOI: 10.1111/j.1600-0765.1985.tb00446.x. View